According to previous studies, higher HIF-1α concentrations have been identified in SCLC and NSCLC, and it has been revealed that these higher HIF-1α concentrations may be associated with disease stage, survival, and treatment response (32, 33). Here, HIF1A is linked to non-small cell lung carcinoma.